Refine
Has Fulltext
- yes (14)
Is part of the Bibliography
- yes (14)
Document Type
- Journal article (14)
Language
- English (14)
Keywords
- radioligand therapy (4)
- CXCR4 (3)
- PSMA (3)
- prostate cancer (3)
- theranostics (3)
- C-X-C motif chemokine receptor 4 (2)
- PET (2)
- PET/CT (2)
- [68Ga]PentixaFor (2)
- endoradiotherapy (2)
- <sup>18</sup>F-FDG (1)
- <sup>68</sup>Ga-Pentixafor (1)
- COVID-19 (1)
- CTCAE (1)
- CXCR4-targeting (1)
- MIBG (1)
- NEC (1)
- NET (1)
- PRRT (1)
- PSA (1)
- PSMA-RADS (1)
- RADS (1)
- RLT (1)
- SARS-CoV-2 (1)
- SSTR-RADS (1)
- SUV (1)
- [177Lu]/[90Y]PentixaTher (1)
- [177Lu]Lu-PSMA I&T (1)
- [177Lu]PentixaTher (1)
- [90Y]PentixaTher (1)
- [\(^{68}\)Ga]Ga-FAPI (1)
- \(^{177}\)Lu (1)
- \(^{18}\)F-PSMA-1007 (1)
- adrenocortical carcinoma (1)
- angiogenesis (1)
- blood flow (1)
- cardiac nerve (1)
- combination (1)
- fibroblast activation protein (1)
- flare phenomenon (1)
- hematotoxicity (1)
- immune infiltration (1)
- inflammation (1)
- late response (1)
- mRNA (1)
- machine learning (1)
- miRNA (1)
- molecular imaging (1)
- multiple myeloma (1)
- nephrotoxicity (1)
- neuroendocrine tumor (1)
- overall survival (1)
- papillary thyroid carcinoma (PTC) (1)
- peptide receptor radionuclide therapy (1)
- prediction (1)
- radioiodine (1)
- reporting and data system (1)
- selpercatinib (1)
- staging (1)
- standardized reporting system (1)
- statin (1)
- sympathetic nervous system (1)
- thyroid carcinoma (TC) (1)
- transcriptome (1)
- tumor microenvironment (1)
Institute
- Klinik und Poliklinik für Nuklearmedizin (14)
- Urologische Klinik und Poliklinik (5)
- Medizinische Klinik und Poliklinik I (4)
- Medizinische Klinik und Poliklinik II (3)
- Comprehensive Cancer Center Mainfranken (2)
- Pathologisches Institut (2)
- Center for Computational and Theoretical Biology (1)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (1)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (1)
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (1)
Purpose of Review
Statins are routinely applied in patients with coronary artery disease, as they allow significantly to reduce blood cholesterol levels. Although those drugs are endorsed by current guidelines and prescribed routinely, a substantial portion of patients are still statin-intolerant and image-piloted strategies may then be helpful to identify patients that need further intensified treatment, e.g., to initiate treatment with proprotein convertase subtilisin / kexin type 9 inhibitors (PCSK9i). In addition, it has also been advocated that statins exhibit nonlipid, cardio-protective effects including improved cardiac nerve integrity, blood flow, and anti-inflammatory effects in congestive heart failure (HF) patients.
Recent Findings
In subjects after myocardial infarction treated with statins, \(^{123}\)I-metaiodobenzylguanidine (MIBG) scintigraphy has already revealed enhanced cardiac nerve function relative to patients without statins. In addition, all of those aforementioned statin-targeted pathways in HF can be visualized and monitored using dedicated cardiac radiotracers, e.g., \(^{123}\)I-MIBG or \(^{18}\)F-AF78 (for cardiac nerve function), \(^{18}\)F-flurpiridaz (to determine coronary flow) or \(^{68}\)Ga-PentixaFor (to detect inflammation).
Summary
Statins exhibit various cardio-beneficial effects, including improvement of cardiac nerve function, blood flow, and reduction of inflammation, which can all be imaged using dedicated nuclear cardiac radiotracers. This may allow for in vivo monitoring of statin-induced cardioprotection beyond lipid profiling in HF patients.